Vanguard Group Inc Gossamer Bio, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,410,792 shares of GOSS stock, worth $22 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,410,792
Previous 10,083,881
13.16%
Holding current value
$22 Million
Previous $11.1 Million
26.53%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding GOSS
# of Institutions
136Shares Held
159MCall Options Held
2.89MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$35.4 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$34.9 Million1.84% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$15.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$13.8 Million0.02% of portfolio
-
683 Capital Management, LLC New York, NY6.34MShares$12.2 Million0.61% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $181M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...